Zacks Small Cap Research on MSN
MTVA: No evidence for changes in cardiovascular parameters in phase 1 trial of DA-1726
By David Bautz, PhD NASDAQ: MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Treatment with DA-1726 Shows No Evidence ...
The risk for major adverse cardiovascular events appeared similar between older patients treated with 5-aminosalicylic acid ...
For years, body mass index, or BMI, was considered the standard way to evaluate health risk related to weight. But many cardiologists and metabolic health researchers now believe BMI tells only part ...
A new study suggests that the current exercise guidelines of 150 minutes per week may offer modest cardiovascular protection, ...
Many people assume they would know if they had a heart rhythm problem, but that is not always the case. According to Dr. Gurjit Singh-Uppal, Electrophysiologist with California Cardiovascular ...
Cardiomyopathy is a group of diseases that weaken the heart muscle and are a leading cause of heart failure and sudden ...
Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Where do we stand on ...
Researchers say adults may need to quadruple the current weekly exercise recommendations to achieve substantial heart health ...
In this first episode of a two-part Double Take miniseries on cardiovascular risk factors from the New England Journal of Medicine, five key drivers of cardiovascular disease are reviewed. The video ...
Primary care practitioners serve a critical role in optimizing clinical outcomes for adults with type 2 diabetes.
Cardiovascular growth at scale requires coordinating remote monitoring workflows across subspecialties to improve data integration and patient care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results